重组人活化蛋白C治疗严重脓毒症：从中吸取的教训？ - Suppr

Suppr

超能文献

Recombinant human activated protein C as a therapy for severe sepsis: lessons learned?

作者信息

Opal Steven M, LaRosa Steven P

出版信息

Am J Respir Crit Care Med. 2013 May 15;187(10):1041-3. doi: 10.1164/rccm.201303-0505ED.

DOI:10.1164/rccm.201303-0505ED

PMID:23675711

Abstract

摘要

相似文献

Recombinant human activated protein C as a therapy for severe sepsis: lessons learned?

Am J Respir Crit Care Med. 2013 May 15;187(10):1041-3. doi: 10.1164/rccm.201303-0505ED.

[On activated protein C in septic shock].

Presse Med. 2006 Jun;35(6 Pt 1):989; author reply 989.

Sepsis update: management of severe sepsis and septic shock in the emergency department after the withdrawal of Xigris.

CJEM. 2012 Sep;14(5):265-9. doi: 10.2310/8000.2012.120769.

Septic shock--evaluating another failed treatment.

N Engl J Med. 2012 May 31;366(22):2122-4. doi: 10.1056/NEJMe1203412. Epub 2012 May 22.

Use of activated protein C in a case of paediatric septic shock.

Minerva Pediatr. 2005 Dec;57(6):429-32.

Drotrecogin alpha (activated) in septic shock after lung transplant.

J Heart Lung Transplant. 2008 Jul;27(7):815. doi: 10.1016/j.healun.2008.04.002. Epub 2008 May 12.

Drotrecogin alpha (activated) in neonatal septic shock.

Scand J Infect Dis. 2005;37(4):306-8. doi: 10.1080/00365540510031412.

Effectiveness of human recombinant activated protein C for severe sepsis and septic shock in adult and pediatric patients: randomized clinical trial versus nonrandomized study.

Crit Care Med. 2013 Jul;41(7):e139. doi: 10.1097/CCM.0b013e31828c2500.

"All in" for a huge pot: the PROWESS-SHOCK trial for refractory septic shock.

Surg Infect (Larchmt). 2007 Oct;8(5):491-4. doi: 10.1089/sur.2007.9980.

[Activated protein C in patients with septic shock: pro].

Dtsch Med Wochenschr. 2010 Nov;135(47):2370. doi: 10.1055/s-0030-1269402. Epub 2010 Nov 16.

引用本文的文献

Fibrin-modulating nanogels for treatment of disseminated intravascular coagulation.

Blood Adv. 2021 Feb 9;5(3):613-627. doi: 10.1182/bloodadvances.2020003046.

Intensive care in 2050: healthcare expenditure.

Intensive Care Med. 2017 Aug;43(8):1141-1143. doi: 10.1007/s00134-017-4679-2. Epub 2017 Feb 1.

Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.

FASEB J. 2017 Feb;31(2):761-770. doi: 10.1096/fj.201600912R. Epub 2016 Nov 11.

Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.

FASEB J. 2015 Aug;29(8):3483-92. doi: 10.1096/fj.15-271213. Epub 2015 May 7.

Overexpression of activated protein C hampers bacterial dissemination during pneumococcal pneumonia.

BMC Infect Dis. 2014 Nov 4;14:559. doi: 10.1186/s12879-014-0559-3.

Targeting the host hemostatic system function in bacterial infection for antimicrobial therapies.

J Thromb Thrombolysis. 2014 Jan;37(1):66-73. doi: 10.1007/s11239-013-0994-9.

A multibiomarker-based outcome risk stratification model for adult septic shock*.

Crit Care Med. 2014 Apr;42(4):781-9. doi: 10.1097/CCM.0000000000000106.

Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Front Immunol. 2013 Nov 18;4:387. doi: 10.3389/fimmu.2013.00387.

The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?

Virulence. 2014 Jan 1;5(1):45-56. doi: 10.4161/viru.26516. Epub 2013 Sep 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验